| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.27 | 0.0003 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |